From January 1, 2024 to January 28, 2024, the company has repurchased 294,200 shares, representing 0.04% for CNY 1.65 million. With this, the company has completed the repurchase of 8,785,900 shares, representing 1.17% for CNY 50 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.97 CNY | +1.22% | -2.55% | -10.13% |
1st Jan change | Capi. | |
---|---|---|
-10.13% | 478M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.63B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.